GCG and Blindness: In conclusion, this systematic review and meta‐analysis demonstrates that GLP‐1 or dual GIP/GLP‐1 RAs are associated with a significantly lower risk of papilledema and visual disturbances or blindness compared with the standard of care, while GLP‐1 RAs also significantly reduce the monthly headache burden in IIH.